Role of arsenolite on 8-isoprostane of asthmatic mice plasm.
- Author:
Dong-ming LI
1
;
Jia-xing XIE
;
Biao LIANG
Author Information
- Publication Type:Journal Article
- MeSH: Animals; Anti-Asthmatic Agents; pharmacology; Arsenicals; pharmacology; Asthma; blood; chemically induced; physiopathology; Bronchoalveolar Lavage Fluid; cytology; Dinoprost; analogs & derivatives; blood; Leukocyte Count; Male; Materia Medica; pharmacology; Mice; Ovalbumin; Oxides; pharmacology; Random Allocation; Respiratory Function Tests
- From: China Journal of Chinese Materia Medica 2005;30(22):1758-1760
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVEThrough the establishment of mouse' ovalbumin- sensitized asthmatic model and the observation of the 8-Isoprostane of plasm, to evaluate the therapeutic effects of arsenolite on asthmatic mice.
METHODForty-two healthy Kunming male mice were randomly divided into control group and experience groups, the latter were treated with dexamethasone, arsenolite. Lung function were tested, 8-isoprostane of plasm and WBC of BALF were measured.
RESULTLung function improved after treating with dexamethasone or arsenolite. The WBC of asthmatic mice were significantly higher than those in control group, and decreased after treating with dexamethasone or arsenolite; 8-Isoprostane of plasm in asthmatic mice was higher than that of control group, and decreased after treating with dexamethasone or arsenolite.
CONCLUSIONThere is oxidant stress status in asthmatic mice. Arsenolite could lighten airway obstruction, reduce airway high response and redress oxidant stress status in asthmatic mice.